Cita APA

Östör, A., Van den Bosch, F., Papp, K., Keiserman, M., Blanco Alonso, R., Crowley, A., . . . Kivitz, A. (2025). Efficacy and safety of risankizumab for active psoriatic arthritis: 196-week results from the KEEPsAKE 1 and KEEPsAKE 2 randomized clinical trials.

Citación estilo Chicago

Östör, Andrew, et al. Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-week Results From the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials. 2025.

Cita MLA

Östör, Andrew, et al. Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-week Results From the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials. 2025.